ONS - Oncobiologics, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue9/30/20179/30/20169/30/2015
Total Revenue3,811.5192,979.5765,219.237
Cost of Revenue---
Gross Profit3,811.5192,979.5765,219.237
Operating Expenses
Research Development23,809.74932,763.17838,876.04
Selling General and Administrative15,882.03321,563.57312,905.823
Non Recurring---
Others---
Total Operating Expenses---
Operating Income or Loss-35,880.263-51,347.175-46,562.626
Income from Continuing Operations
Total Other Income/Expenses Net3,158.4693,158.4693,158.469
Earnings Before Interest and Taxes-38,347.627-53,198.989-48,859.965
Interest Expense---
Income Before Tax-38,347.627-53,198.989-48,859.965
Income Tax Expense501.5103-190.111
Minority Interest---654.417
Net Income From Continuing Ops-38,849.127-53,301.989-47,393.283
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-38,849.127-53,301.989-47,393.283
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-40,025.87-63,138.969-52,998.402